On the afternoon of March 21, 2025, the scientific seminar “Introduction of IVACRIG Rabies Immunoglobulin” was successfully held at the Auditorium of Xuyen A General Hospital, Ho Chi Minh City. The event was co-organized by Naviva Group – Nam Hung Viet Vaccine & Biological Products JSC and the Institute of Vaccines and Medical Biologicals (IVAC), with the participation of doctors, healthcare professionals, and representatives from four hospitals within the Xuyen A General Hospital System.
Key Highlights of the Seminar
According to the World Health Organization (WHO), more than 10 million people are bitten each year by rabid or suspected rabid animals and require post-exposure prophylaxis with rabies vaccines. The mortality rate of rabies is extremely high, nearly 100%. According to the Department of Preventive Medicine, in 2024, Vietnam recorded more than 80 rabies-related deaths across 33 provinces and cities. Timely administration of rabies vaccines and rabies immunoglobulin, under the proper guidance of doctors, is currently the safest and most effective method of rabies prevention.
The seminar was an opportunity for doctors and healthcare professionals to update the latest information on IVACRIG Rabies Immunoglobulin. Experts from the Institute of Vaccines and Medical Biologicals (IVAC), particularly Dr. Duong Huu Thai, MD, PhD – Director of IVAC, delivered an insightful presentation on the manufacturing process, clinical applications, and efficacy of IVACRIG.
Key topics included:
✅ Rabies epidemiology in Vietnam
✅ Introduction of IVACRIG Rabies Immunoglobulin
✅ Expert discussions and clinical guidance on the appropriate use of IVACRIG
Image: IVACRIG Rabies Immunoglobulin
Naviva Group – Trusted Partner in Vaccines and Biologicals Marketing & Distribution
As a leading distributor of vaccines and biological products in Vietnam, Naviva Group is proud to collaborate with doctors and healthcare professionals in the mission of safeguarding community health. We are committed to delivering high-quality, safe, and effective products, thereby contributing to enhanced healthcare standards and improved public health in Vietnam.
Naviva Group is currently distributing a diverse portfolio of vaccines and immunoglobulins, including the rabies immunoglobulin IVACRIG. We are proud to be a trusted, long-standing partner of the Institute of Vaccines and Medical Biologicals (IVAC), ensuring timely and efficient delivery of products to healthcare facilities.
📸 Here are some of the key moments captured from the seminar:
NAVIVA GROUP extends our sincere gratitude to the distinguished delegates, doctors, and healthcare professionals who attended the seminar in person, as well as those who joined online. Your support and contributions are the driving force that inspire us to continue delivering the best products and services in pursuit of our mission to protect community health.
We look forward to welcoming you at upcoming scientific events hosted by Naviva Group!
📞 For inquiries regarding IVACRIG Rabies Immunoglobulin, please contact:
- Nam Hung Viet Vaccine & Biological Products JSC
44, Street No.12, Him Lam Urban Area, Tan Hung Ward, District 7, Ho Chi Minh City
Tel: 028 6266 1234 (5 lines) - Tuong Khue Pharmaceutical JSC
33 Le Lai, Hai Chau District, Da Nang City
Tel: 0236 3538 666 (4 lines) - WINBIO JSC
K7TT1 – SH19, Starlake Urban Area, Xuan La Ward, Tay Ho District, Hanoi
Tel: 024 3795 6789 (3 lines)
NAVIVA GROUP
“Community health is our happiness”
